1. Larson EB, Reifler BV, Sumi SM, Canfield CG, Chinn NM. Features of potentially reversible dementia in elderly outpatients. West J Med. 1986;145(4):488–92.
2. Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987;107(2):169–73.
3. Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med. 1988;109(6):476–86.
4. National Center for Health Statistics. National Health and Nutrition Examination Survey: prescription drug use in the past 30 days, by sex, race and Hispanic origin, and age: United States, selected years 1988–1994 through 2015–2018—Con. 2019. https://www.cdc.gov/nchs/data/hus/2019/039-508.pdf. Accessed 16 Sep 2023.
5. FDA Adverse Event Reporting System (FAERS) Public Dashboard. https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard. Accessed 16 Sep 2023.